182 related articles for article (PubMed ID: 14500110)
1. Emotion perception in schizophrenia: an eye movement study comparing the effectiveness of risperidone vs. haloperidol.
Williams LM; Loughland CM; Green MJ; Harris AW; Gordon E
Psychiatry Res; 2003 Aug; 120(1):13-27. PubMed ID: 14500110
[TBL] [Abstract][Full Text] [Related]
2. Visual scanpaths to positive and negative facial emotions in an outpatient schizophrenia sample.
Loughland CM; Williams LM; Gordon E
Schizophr Res; 2002 May; 55(1-2):159-70. PubMed ID: 11955975
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia and affective disorder show different visual scanning behavior for faces: a trait versus state-based distinction?
Loughland CM; Williams LM; Gordon E
Biol Psychiatry; 2002 Aug; 52(4):338-48. PubMed ID: 12208641
[TBL] [Abstract][Full Text] [Related]
4. [Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol].
Dittert S; Soyka M; Winter C; Möller HJ
Fortschr Neurol Psychiatr; 1999 Nov; Suppl 2():S70-3. PubMed ID: 10598340
[No Abstract] [Full Text] [Related]
5. Risperidone versus haloperidol for facial affect recognition in schizophrenia: findings from a randomised study.
Fakra E; Salgado-Pineda P; Besnier N; Azorin JM; Blin O
World J Biol Psychiatry; 2009; 10(4 Pt 3):719-28. PubMed ID: 17853271
[TBL] [Abstract][Full Text] [Related]
6. Adverse effects of risperidone on eye movement activity: a comparison of risperidone and haloperidol in antipsychotic-naive schizophrenic patients.
Sweeney JA; Bauer KS; Keshavan MS; Haas GL; Schooler NR; Kroboth PD
Neuropsychopharmacology; 1997 Mar; 16(3):217-28. PubMed ID: 9138438
[TBL] [Abstract][Full Text] [Related]
7. Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls.
Soyka M; Winter C; Kagerer S; Brunnauer M; Laux G; Möller HJ
J Psychiatr Res; 2005 Jan; 39(1):101-8. PubMed ID: 15504428
[TBL] [Abstract][Full Text] [Related]
8. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
9. Impaired recognition of happy, sad and neutral expressions in schizophrenia is emotion, but not valence, specific and context dependent.
Silver H; Bilker W; Goodman C
Psychiatry Res; 2009 Sep; 169(2):101-6. PubMed ID: 19692127
[TBL] [Abstract][Full Text] [Related]
10. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
[TBL] [Abstract][Full Text] [Related]
11. Differential brain activation during facial emotion discrimination in first-episode schizophrenia.
Reske M; Habel U; Kellermann T; Backes V; Jon Shah N; von Wilmsdorff M; Gaebel W; Zilles K; Schneider F
J Psychiatr Res; 2009 Mar; 43(6):592-9. PubMed ID: 19056093
[TBL] [Abstract][Full Text] [Related]
12. Risperidone in treatment-refractory schizophrenia.
Wirshing DA; Marshall BD; Green MF; Mintz J; Marder SR; Wirshing WC
Am J Psychiatry; 1999 Sep; 156(9):1374-9. PubMed ID: 10484947
[TBL] [Abstract][Full Text] [Related]
13. Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
Int Clin Psychopharmacol; 2001 Nov; 16(6):325-30. PubMed ID: 11712620
[TBL] [Abstract][Full Text] [Related]
14. Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings.
Kee KS; Kern RS; Marshall BD; Green MF
Schizophr Res; 1998 May; 31(2-3):159-65. PubMed ID: 9689720
[TBL] [Abstract][Full Text] [Related]
15. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
16. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
[TBL] [Abstract][Full Text] [Related]
17. Risperidone versus haloperidol: I. Meta-analysis of efficacy and safety.
Davies A; Adena MA; Keks NA; Catts SV; Lambert T; Schweitzer I
Clin Ther; 1998; 20(1):58-71. PubMed ID: 9522104
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
Alptekin K; Hafez J; Brook S; Akkaya C; Tzebelikos E; Ucok A; El Tallawy H; Danaci AE; Lowe W; Karayal ON
Int Clin Psychopharmacol; 2009 Sep; 24(5):229-38. PubMed ID: 19531959
[TBL] [Abstract][Full Text] [Related]
19. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T
Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
[TBL] [Abstract][Full Text] [Related]
20. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
